Il 1 Receptor Antagonists: - Cancer Science

Relevant Publications

Betahistine\'s Neuroprotective Actions against Lipopolysaccharide-Induced Neurotoxicity: Insights from Experimental and Computational Studies.

Issue Release: 2024

Autoantibody mediated Deficiency of IL-36-Receptor antagonist in a subset of patients with Psoriasis and Psoriatic Arthritis.

Issue Release: 2024

Alpha-1 adrenergic antagonists and the risk of hospitalization or death in non-hospitalized patients with COVID-19: A population-based study.

Issue Release: 2024

Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression.

Issue Release: 2024

Exercise-induced β2-adrenergic receptor activation enhances the anti-leukemic activity of expanded γδ T-Cells via DNAM-1 upregulation and PVR/Nectin-2 recognition.

Issue Release: 2024

Epstein-Barr Virus Promotes Inflammatory Cytokine Production in Human Gingival Fibroblasts.

Issue Release: 2024

Chemokine Receptor Antagonists Prevent and Reverse Cofilin-Actin Rod Pathology and Protect Synapses in Cultured Rodent and Human iPSC-Derived Neurons.

Issue Release: 2024

Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs.

Issue Release: 2024

Adenosine Increases the Immunosuppressive Capacity of Cervical Cancer Cells by Increasing PD-L1 Expression and TGF-β Production through Its Interaction with AR/AR.

Issue Release: 2024

VEXAS and Myelodysplastic Syndrome: An Interdisciplinary Challenge.

Issue Release: 2024

Tocilizumab for treating mevalonate kinase deficiency and TNF receptor-associated periodic syndrome: a case series and literature review.

Issue Release: 2024

Gastric digestion of the sweet-tasting plant protein thaumatin releases bitter peptides that reduce H. pylori induced pro-inflammatory IL-17A release via the TAS2R16 bitter taste receptor.

Issue Release: 2024

Establishment of a human nasal epithelium model of histamine-induced inflammation to assess the activity of fexofenadine as an inverse agonist and its link to clinical benefit.

Issue Release: 2024

Persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a review of definitions, potential therapies, and research priorities.

Issue Release: 2024

The thrombin receptor PAR4 supports visceral adipose tissue inflammation.

Issue Release: 2024

Semaphorin 7A impairs barrier function in cultured human corneal epithelial cells in a manner dependent on nuclear factor-kappa B.

Issue Release: 2024

The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis.

Issue Release: 2024

Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression.

Issue Release: 2024

Exploring Cytokines Dynamics: Uncovering Therapeutic Concepts for Metabolic Disorders in Postmenopausal Women- Diabetes, Metabolic Bone Diseases, and Non-Alcohol Fatty Liver Disease.

Issue Release: 2024

SPH7854, a gut-limited RORγt antagonist, ameliorates TNBS-induced experimental colitis in rat.

Issue Release: 2024

What role do biomarkers play in cancer treatment?

How Do Blister Packs Benefit Cancer Patients?

How to Prepare for Bone Marrow Aspiration?

What are the Benefits of Telemedicine in Cancer Care?

Which Types of Cancer Are Most Commonly Associated with Dysphagia?

How do Keratins Affect Tumor Behavior?

Which Cancers are Associated with MSI-H?

What are the Challenges in Using Natural Compounds for Cancer Treatment?

How is Processed Meat Linked to Cancer?

Why is Tumor Location Important in Cancer?

Il 1 Receptor Antagonists: - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics